Morphine (Sulfate) Lavoisier (Morphine Sulfate)

Morphine sulfate, the active ingredient in Morphine (Sulfate) Lavoisier, is an opioid analgesic presented as a sterile injectable solution for intravenous, oral, and subcutaneous use. It is employed to treat moderate to severe acute, postoperative, cancer‑related and chronic pain in adult patients.

GNH USA supplies Morphine (Sulfate) Lavoisier as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine sulfate is an opioid analgesic used to manage pain across several clinical contexts.

- Moderate to severe acute pain: provides rapid relief of intense pain episodes. - Postoperative pain: controls pain following surgical procedures. - Cancer pain: alleviates persistent pain associated with malignant disease. - Severe chronic pain: offers long‑term management for refractory chronic pain conditions.

Morphine sulfate may cause a range of adverse reactions, varying from mild to life‑threatening.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness or unsteadiness. - Itching: mild pruritus, often without rash. - Dry mouth: reduced salivation leading to a dry oral cavity.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Hypotension: significant drop in blood pressure. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Adrenal insufficiency: impaired cortisol production. - Seizures: rare occurrence of convulsive episodes. - Cardiac arrhythmias: abnormal heart rhythms.

When prescribing or handling morphine sulfate, several safety considerations are essential.

- Respiratory assessment: evaluate baseline respiratory function and monitor for depression. - Dependence risk: assess patient history for substance use disorder and limit duration of therapy. - Dose adjustment: modify dosing in renal or hepatic impairment. - Concomitant CNS depressants: avoid or use with caution when combined with benzodiazepines or alcohol. - Elderly patients: start with lower doses and monitor closely for adverse effects. - Store at room temperature: keep in original container, protect from moisture and light.

Morphine sulfate can interact with other medications, altering its safety or efficacy.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - Central nervous system depressants (e.g., benzodiazepines): increased risk of profound sedation. - Monoamine oxidase inhibitors (MAOIs): potential for severe hypotension or serotonin syndrome. - Alcohol: enhances CNS depression and respiratory effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect. - Antihistamines: can augment sedation. - Diuretics: may exacerbate hypotension. - Anticholinergics: may worsen constipation.